These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 23793098)

  • 1. Association of HLA-DRB1-restricted CD4⁺ T cell responses with HIV immune control.
    Ranasinghe S; Cutler S; Davis I; Lu R; Soghoian DZ; Qi Y; Sidney J; Kranias G; Flanders MD; Lindqvist M; Kuhl B; Alter G; Deeks SG; Walker BD; Gao X; Sette A; Carrington M; Streeck H
    Nat Med; 2013 Jul; 19(7):930-3. PubMed ID: 23793098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of HLA-DRB1 allele polymorphisms on control of HIV infection in a Peruvian MSM cohort.
    Oriol-Tordera B; Llano A; Ganoza C; Cate S; Hildebrand W; Sanchez J; Calle ML; Brander C; Olvera A
    HLA; 2017 Oct; 90(4):234-237. PubMed ID: 28677168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV Controllers Exhibit Enhanced Frequencies of Major Histocompatibility Complex Class II Tetramer
    Laher F; Ranasinghe S; Porichis F; Mewalal N; Pretorius K; Ismail N; Buus S; Stryhn A; Carrington M; Walker BD; Ndung'u T; Ndhlovu ZM
    J Virol; 2017 Apr; 91(7):. PubMed ID: 28077659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Possession of HLA class II DRB1*1303 associates with reduced viral loads in chronic HIV-1 clade C and B infection.
    Julg B; Moodley ES; Qi Y; Ramduth D; Reddy S; Mncube Z; Gao X; Goulder PJ; Detels R; Ndung'u T; Walker BD; Carrington M
    J Infect Dis; 2011 Mar; 203(6):803-9. PubMed ID: 21257739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective HLA alleles are associated with reduced LPS levels in acute HIV infection with implications for immune activation and pathogenesis.
    Claiborne DT; Scully EP; Palmer CD; Prince JL; Macharia GN; Kopycinski J; Michelo CM; Wiener HW; Parker R; Nganou-Makamdop K; Douek D; Altfeld M; Gilmour J; Price MA; Tang J; Kilembe W; Allen SA; Hunter E
    PLoS Pathog; 2019 Aug; 15(8):e1007981. PubMed ID: 31449552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Case report: mechanisms of HIV elite control in two African women.
    Moosa Y; Tanko RF; Ramsuran V; Singh R; Madzivhandila M; Yende-Zuma N; Abrahams MR; Selhorst P; Gounder K; Moore PL; Williamson C; Abdool Karim SS; Garrett NJ; Burgers WA
    BMC Infect Dis; 2018 Jan; 18(1):54. PubMed ID: 29370775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD8+ T Cell Breadth and Ex Vivo Virus Inhibition Capacity Distinguish between Viremic Controllers with and without Protective HLA Class I Alleles.
    Koofhethile CK; Ndhlovu ZM; Thobakgale-Tshabalala C; Prado JG; Ismail N; Mncube Z; Mkhize L; van der Stok M; Yende N; Walker BD; Goulder PJR; Ndung'u T
    J Virol; 2016 Aug; 90(15):6818-6831. PubMed ID: 27194762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA class II-Restricted CD8+ T cells in HIV-1 Virus Controllers.
    Nyanhete TE; Frisbee AL; Bradley T; Faison WJ; Robins E; Payne T; Freel SA; Sawant S; Weinhold KJ; Wiehe K; Haynes BF; Ferrari G; Li QJ; Moody MA; Tomaras GD
    Sci Rep; 2019 Jul; 9(1):10165. PubMed ID: 31308388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA class I-restricted T-cell responses may contribute to the control of human immunodeficiency virus infection, but such responses are not always necessary for long-term virus control.
    Emu B; Sinclair E; Hatano H; Ferre A; Shacklett B; Martin JN; McCune JM; Deeks SG
    J Virol; 2008 Jun; 82(11):5398-407. PubMed ID: 18353945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired Nef function is associated with early control of HIV-1 viremia.
    Kuang XT; Li X; Anmole G; Mwimanzi P; Shahid A; Le AQ; Chong L; Qian H; Miura T; Markle T; Baraki B; Connick E; Daar ES; Jessen H; Kelleher AD; Little S; Markowitz M; Pereyra F; Rosenberg ES; Walker BD; Ueno T; Brumme ZL; Brockman MA
    J Virol; 2014 Sep; 88(17):10200-13. PubMed ID: 24965469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of Abrupt Loss of Virus Control in a Cohort of Previous HIV Controllers.
    Rosás-Umbert M; Llano A; Bellido R; Olvera A; Ruiz-Riol M; Rocafort M; Fernández MA; Cobarsi P; Crespo M; Dorrell L; Del Romero J; Alcami J; Paredes R; Brander C; Mothe B
    J Virol; 2019 Feb; 93(4):. PubMed ID: 30487276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV controllers with HLA-DRB1*13 and HLA-DQB1*06 alleles have strong, polyfunctional mucosal CD4+ T-cell responses.
    Ferre AL; Hunt PW; McConnell DH; Morris MM; Garcia JC; Pollard RB; Yee HF; Martin JN; Deeks SG; Shacklett BL
    J Virol; 2010 Nov; 84(21):11020-9. PubMed ID: 20719952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two Distinct Mechanisms Leading to Loss of Virological Control in the Rare Group of Antiretroviral Therapy-Naive, Transiently Aviremic Children Living with HIV.
    Vieira VA; Adland E; Grayson NE; Csala A; Richards F; Dacon C; Athavale R; Tsai MH; D'Souza R; Muenchhoff M; Bonsall D; Jooste P; Goulder PJR
    J Virol; 2022 Jan; 96(2):e0153521. PubMed ID: 34757843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Control of HIV-1 Pathogenesis in Viremic Nonprogressors Is Independent of Gag-Specific Cytotoxic T Lymphocyte Responses.
    Salgado M; Garcia-Minambres A; Dalmau J; Jiménez-Moyano E; Viciana P; Alejos B; Clotet B; Prado JG; Martinez-Picado J
    J Virol; 2018 Jun; 92(12):. PubMed ID: 29593044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors Associated With the Control of Viral Replication and Virologic Breakthrough in a Recently Infected HIV-1 Controller.
    Walker-Sperling VE; Pohlmeyer CW; Veenhuis RT; May M; Luna KA; Kirkpatrick AR; Laeyendecker O; Cox AL; Carrington M; Bailey JR; Arduino RC; Blankson JN
    EBioMedicine; 2017 Feb; 16():141-149. PubMed ID: 28159573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Possession of human leucocyte antigen DQ6 alleles and the rate of CD4 T-cell decline in human immunodeficiency virus-1 infection.
    Vyakarnam A; Sidebottom D; Murad S; Underhill JA; Easterbrook PJ; Dalgleish AG; Peakman M
    Immunology; 2004 May; 112(1):136-42. PubMed ID: 15096192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA-A*7401-mediated control of HIV viremia is independent of its linkage disequilibrium with HLA-B*5703.
    Matthews PC; Adland E; Listgarten J; Leslie A; Mkhwanazi N; Carlson JM; Harndahl M; Stryhn A; Payne RP; Ogwu A; Huang KH; Frater J; Paioni P; Kloverpris H; Jooste P; Goedhals D; van Vuuren C; Steyn D; Riddell L; Chen F; Luzzi G; Balachandran T; Ndung'u T; Buus S; Carrington M; Shapiro R; Heckerman D; Goulder PJ
    J Immunol; 2011 May; 186(10):5675-86. PubMed ID: 21498667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strong ability of Nef-specific CD4+ cytotoxic T cells to suppress human immunodeficiency virus type 1 (HIV-1) replication in HIV-1-infected CD4+ T cells and macrophages.
    Zheng N; Fujiwara M; Ueno T; Oka S; Takiguchi M
    J Virol; 2009 Aug; 83(15):7668-77. PubMed ID: 19457989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pol-Driven Replicative Capacity Impacts Disease Progression in HIV-1 Subtype C Infection.
    Ojwach DBA; MacMillan D; Reddy T; Novitsky V; Brumme ZL; Brockman MA; Ndung'u T; Mann JK
    J Virol; 2018 Oct; 92(19):. PubMed ID: 29997209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of HIV-specific CD4+ T cell responses against peptides selected with broad population and pathogen coverage.
    Buggert M; Norström MM; Czarnecki C; Tupin E; Luo M; Gyllensten K; Sönnerborg A; Lundegaard C; Lund O; Nielsen M; Karlsson AC
    PLoS One; 2012; 7(7):e39874. PubMed ID: 22792193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.